Icahn School of Medicine at Mount Sinai: Clinical Trials & Research Profile

Academic / Institutional Sponsor (Global / Institutional) · Primary Focus: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationAcademic / Institutional Sponsor (Global / Institutional)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies37 active (33 recruiting now)
Total Tracked Studies (2018 to 2026)68 (3 with California sites)
Completed vs Early-Stopped Studies14 completed / 16 stopped (23.5% stop rate)
Median Closed Enrollment25 participants
FDA Drugs@FDA Original Approvals0 all-time (0 from 2018 to 2026)
Physical Hospital Site Disclosure99.5% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Mount Sinai Health System across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk